-
Pfizer announces clinical trial data of mRNA vaccine vaccination in children aged 5-11
Time of Update: 2021-11-05
The data shows that one month after the completion of two doses of vaccination, the SARS-CoV-2 neutralizing antibody geometric mean titer (GMT) induced in children aged 5 to 11 was 1197.
-
Zhengda Tianqing broke out!
Time of Update: 2021-11-05
Recently, CP Tianqing Pharmaceutical Group's product line has been frequently updated: colorectal cancer drug trefluridine tepipyrimidine tablets have been approved for marketing, class 1 new drugs TQB2916 and TQB2868 have successively applied for INDs, and 210 million yuan has been introduced to introduce long-acting baiyao.
-
Uncharacteristically!
Time of Update: 2021-11-05
Due to the dismal results of the trial, the FDA believes that the company's gradual cryosurgery treatment does not have enough evidence to support its new drug application .
-
Medical representation continues to decrease
Time of Update: 2021-11-05
. Regarding the impact of centralized procurement on domestic and foreign pharmaceutical companies, an industry authority said to Cyberland today that once related products are included in mass procurement, whether they are selected or unsuccessful, the company’s related products do not require pharmaceutical representatives—— This situation has already been manifested earlier, and both Sanofi, who was selected and the unsuccessful Jialin, made the same move and abolished the sales team .
-
Secret: 31 drugs or therapies around the world won the Nobel Prize "New Drug Research and Development" What is the next Nobel Prize?
Time of Update: 2021-11-05
For example, the 2019 Nobel Prize in Physiology or Medicine is awarded to scientists who have made important contributions in the field of oxygen sensing pathway research .
-
Cefmetazole Sodium for Injection, a wholly-owned subsidiary of Haisco passed the consistency evaluation of generic drugs
Time of Update: 2021-11-05
Haisco was approved for injection of cefmetazole sodium in dosage form, specifications, and indications consistent with the original research, and is currently the second generic drug company to be listed on the market through the consistency evaluation .
-
Haoyang Biotech and Hunda Biotech reached a strategic cooperation on antibody-conjugated drugs (ADCs)
Time of Update: 2021-11-05
(hereinafter referred to as "Hunda Bio") jointly announced that they will carry out CDMO service strategic cooperation in the professional field of antibody-conjugated drugs (ADCs), and provide new cooperative solutions for domestic innovative antibody-conjugated drug research and development enterprises Scheme .
-
The price increase of Chinese medicinal materials is good or bad for the centralized procurement of Chinese patent medicines
Time of Update: 2021-11-05
In other words, this time the centralized procurement of proprietary Chinese medicines is approaching, but the raw materials of Chinese medicinal materials have seen a general rise, which will encourage those companies that are preparing to enter the centralized procurement bidding to calculate the production cost based on the current price increase market raw material prices, and then quote in the centralized procurement.
-
The first domestic product! Jiangsu pharmaceutical companies attack $2 billion star drug
Time of Update: 2021-11-05
According to data from Meinenet, in 2020, the total sales of dasatinib tablets in Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 500 million yuan, a year-on-year increase of 21% .
-
Bayer assists the Global Self-care Alliance to release the first "Self-care Readiness Index" report
Time of Update: 2021-11-05
Based on the analysis and recommendations of the "Self-care Readiness Index" report, it will give full play to its own advantages and help Promote science-based health projects and innovations that are accessible to the public .
-
Jingding Pharmaceutical strengthens clinical data and digital service capabilities through important appointments
Time of Update: 2021-11-05
Former GSK executive Stephen Pyke will lead the implementation and development of Jingding Pharmaceutical’s clinical data and digital strategy to better utilize data insights to support Jingding Pharmaceutical’s “patient-centric” strategic focusShanghai, October 12, 2021/PRNewswire/ - Parexel, a leading multinational clinical research organization (CRO) dedicated to the development and delivery of innovative therapies to improve human health, recently announced the appointment of Stephen Pyke is the executive vice president of clinical data and digital services .
-
The Gan-Shaan Union Central Procurement Quotation Decrypts 28 Drugs from 25 Enterprises Enters the Second Bargaining
Time of Update: 2021-11-05
From the rules of selection:If the number of declared companies is 1, the expert group negotiates to produce the result of the selection.
The applying enterprise makes a second quotation, and the expert group negotiates the final selected enterprise .
-
The next new 1 billion injection will be born and Osaikang will enter the game strongly
Time of Update: 2021-11-05
Figure 2: Sales of Roxatidine Hydrochloride Acetate for Injection (Unit: Ten Thousand Yuan)Source: Mi Nei. com, China's public medical institutions terminal competition patternAccording to data from Menet.
-
Yiling Pharmaceutical's Yishen Yangxin Anshen Tablets obtained drug registration certificate
Time of Update: 2021-11-05
Up to now, the company has invested about 26 million yuan in the research and development of the Yishen Yangxin Anshen Tablet project .
-
Green Valley Pharmaceuticals Holds Double Ninth Festival Caring Activities and Joins Hands with Various Parties to Create a Cognitive Impairment Friendly Environment
Time of Update: 2021-11-05
On October 13, a caring activity for patients with Alzheimer's disease called "Remember Memories, Eat Taste" kicked off in the "Green Memory Canteen" at the headquarters of Green Valley Pharmaceuticals, 10 people with mild cognition Elderly people with disabilities were invited to the scene to make Chongyang cakes with company employees and participate in the Jiujiu Memory Garden Party.
-
Violation of the 340B drug discount plan!
Time of Update: 2021-11-05
CompilationFan DongdongA few days ago, news showed that many pharmaceutical manufacturers such as Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi and United Biotech may face fines for violating the 340B drug discount plan .
-
BeiGene declares OX40 agonist antibody
Time of Update: 2021-11-05
BGB-A445 mechanism of actionFrom: BeiGene official websiteAccording to the Insight database, BGB-A445 has started phase I clinical trials abroad as early as December 2019, combined with tislelizumab for the treatment of advanced solid tumors .
-
Baili Pharmaceutical's EGFR/HER3 double antibody was approved for two clinical trials
Time of Update: 2021-11-05
Text|Pharmaceutical Mission HillsThe latest announcement by the Center for Drug Evaluation (CDE) of the State Food and Drug Administration of China shows that the Class 1 new drug SI-B001 bispecific a
-
1 billion cephalosporin injection Haisco overtakes the first review
Time of Update: 2021-11-05
0 Chinese Drug Evaluation DatabaseAccording to data from Mi Nei. com, as of now, Haisco and its subsidiaries have reviewed/deemedly reviewed 19 products (including the approved products this time), of which 10 are injections .
-
A number of well-known pharmaceutical companies have been sold to further increase the concentration of the pharmaceutical industry?
Time of Update: 2021-11-05
Kyrgyzstan Pharmaceutical HoldingsKyrgyzstan Pharmaceutical HoldingsOn September 27, Jilin Pharmaceutical Holdings issued a reminder announcement on planning for the sale of major assets and signing the "Share Transfer Framework Agreement", announcing that it would sell 99.
